Live Breaking News & Updates on First In Class Lead

Stay updated with breaking news from First in class lead. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Immutep : Corporate Presentation -March 26, 2024 at 08:12 am EDT

Forward-Looking Statements

The purpose of the presentation is to provide an update of the business of Immutep Limited ACN 009 237 889 . These slides have been. ....

Immutep Limited , First In Class Lead , Nature Reviews Drug Discovery , Checkpoint Discovery , Approval Timeline , Chief Scientific Officer , Checkpoint Inhibitors , Asthma Reports , Major Histocompatibility Complex Class , Neck Squamous Cell Carcinoma , Non Small Cell Lung Cancer , Breast Cancer , Ulcerative Colitis , Investigator Initiated Trials , Stimulate Immune System , Immune Effect Leading , Positive Clinical , Year Survival , Combined Nivolumab , Advanced Melanoma , Untreated Advanced Melanoma ,